Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2012
06/14/2012WO2012030050A9 Pharmaceutical composition for prevention or treatment of degenerative neurological brain disorders
06/14/2012WO2012024293A3 Medical foods for the treatment of developmentally-based neuropsychiatric disorders via modulation of brain glycine and glutathione pathways
06/14/2012WO2012012676A3 Use of mir-29 for cell protection
06/14/2012US20120149778 Compounds
06/14/2012US20120149768 Pkc-activating compounds for the treatment of neurodegenerative diseases
06/14/2012US20120149766 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses
06/14/2012US20120149757 Compositions and methods for modulation of smn2 splicing
06/14/2012US20120149756 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
06/14/2012US20120149754 Methods for modulating the expression and aggregation of cag-expanded gene product in cells and methods for identifying agents useful for doing the same
06/14/2012US20120149752 Kit for balancing neurotransmitter levels
06/14/2012US20120149743 Selenophene and Selenazole Carboxylic Acid Derivatives
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149737 Therapeutic Aryl-Amido-Aryl Compounds and Their Use
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149735 1,4-Dihydropyridine Derivatives and Their Uses
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149728 Novel fumarate salts of a histamine h3 receptor antagonist
06/14/2012US20120149724 Modulating endogenous beta-endorphin levels
06/14/2012US20120149723 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
06/14/2012US20120149718 Amido Compounds
06/14/2012US20120149717 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
06/14/2012US20120149711 Piperidine derivatives used as orexin antagonists
06/14/2012US20120149703 Aza-substituted spiro derivatives
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149699 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS
06/14/2012US20120149698 Nouvel compounds
06/14/2012US20120149697 Humic substances and therapeutic uses thereof
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149685 Composition and method for the treatment of tauopathies
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149680 Kinase inhibitors
06/14/2012US20120149677 Ether benzotriazole derivatives
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149656 WATER SOLUTION OF 20(R) - GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120149646 Long term potentiation with cyclic-glur6 analogs
06/14/2012US20120149645 Compositions and modulation of myocyte enhancer factor 2 (mef2)
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120148689 Film comprising active drugs
06/14/2012US20120148683 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
06/14/2012US20120148679 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition
06/14/2012US20120148677 Controlled release particles containing acid fibroblast growth factor
06/14/2012US20120148672 Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
06/14/2012US20120148671 Gastric retained gabapentin dosage form
06/14/2012US20120148654 Method and system for a photoresist-based immunoisolative microcontainer with nanoslots defined by nanoimprint lithography
06/14/2012US20120148634 Novel formulation of naproxen
06/14/2012US20120148603 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/14/2012US20120148591 Antibodies That Bind Amyloid Oligomers
06/14/2012US20120148586 Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
06/14/2012US20120148583 Cytokine antagonists for neurological and neuropsychiatric disorders
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148560 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
06/14/2012US20120148550 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
06/14/2012US20120148549 Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate
06/14/2012US20120148548 Joint Repair Using Mesenchymal Stem Cells
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148521 Methods and Compositions for Controlled Release of Drugs
06/14/2012US20120148499 Peptides and aptamers for targeting of neuron or nerves
06/14/2012US20120148496 Method of Altering Reaction Time
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012CA2823642A1 Subcutaneously infusible levodopa prodrug compositions and methods of infusion
06/14/2012CA2820763A1 Multifunctional nitroxide derivatives and uses thereof
06/14/2012CA2820431A1 Dosage form
06/14/2012CA2820262A1 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2819595A1 Methods and compositions useful for promoting sleep in animals
06/14/2012CA2819277A1 Novel triazole compounds iii
06/14/2012CA2819087A1 Carboxamide compounds and their use as calpain inhibitors v
06/14/2012CA2818028A1 Hydroxylated tricyclic compounds
06/14/2012CA2817205A1 Hydantoin derivatives useful as kv3 inhibitors
06/14/2012CA2816829A1 Triazolopyridine compounds
06/13/2012EP2463372A1 Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
06/13/2012EP2463369A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463368A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463292A1 Compound having neurite-outgrowing activity
06/13/2012EP2463286A1 Benzyl piperidine compound
06/13/2012EP2463278A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
06/13/2012EP2463276A1 Nitrogenous-ring acylguanidine derivative
06/13/2012EP2462990A1 Pharmaceutical composition comprising lacosamide and levetiracetam with synergistic anticonvulsant effect
06/13/2012EP2462989A1 Use of compounds to induce axonal growth
06/13/2012EP2462927A1 Transdermal therapeutic system comprising fentanyl
06/13/2012EP2462162A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462161A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462147A1 Conformationally constrained, fully synthetic macrocyclic compounds
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP2462131A2 Compositions and methods for treating beta-amyloid related diseases
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 1833